GlassScriptPhysician profile
Katie E Drake
NPI 1174504484
$1,524.46
in general payments reported to CMS, 2019-2025
15 companies · $14.44 in 2025
The $14.44 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.64 · 2020: $124 · 2021: $312 · 2022: $595 · 2023: $99.68 · 2024: $353 · 2025: $14.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $467.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $419.24 | 2019-2024 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $295.68 | 2021-2024 | Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $217.37 | 2021-2022 | |
| Mylan Specialty L.P. | $204.60 | 2021-2022 | |
| Lilly USA, LLC | $108.54 | 2021-2024 | Mounjaro, Jardiance |
| Amgen INC. | $59.52 | 2023-2024 | Repatha, Otezla |
| Exact Sciences Corporation | $54.09 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $32.16 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| Amarin Pharma, INC. | $23.56 | 2021 | |
| Dexcom, INC. | $22.82 | 2024 | Dexcom G6 Transmitter |
| Biogen, INC. | $20.02 | 2021 | |
| Renalytix Ai, INC. | $19.23 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Abbott Laboratories | $17.68 | 2022 | |
| Novo Nordisk INC | $16.61 | 2023 | Wegovy |
| Philips North America LLC | $13.34 | 2024 | (Ck7) Extended Holter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Drake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.